{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:17:12Z","timestamp":1773955032349,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T00:00:00Z","timestamp":1469836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12026-016-8838-2","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T07:27:41Z","timestamp":1469863661000},"page":"299-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic accuracy of two tests for determination of anti-m2 in the diagnosis of primary biliary cirrhosis: Is it possible to predict the course of the disease?"],"prefix":"10.1007","volume":"65","author":[{"given":"Antonio Maria","family":"Alfano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Romito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Battistini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giliola","family":"Crotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Ferrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mancinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilde","family":"Manetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Mengozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Merlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Migliardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Tambuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,30]]},"reference":[{"key":"8838_CR1","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","volume":"377","author":"C Selmi","year":"2011","unstructured":"Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet. 2011;377:1600\u20139.","journal-title":"Lancet"},{"key":"8838_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","volume":"174","author":"ME Gershwin","year":"2000","unstructured":"Gershwin ME, Ansari AA, Mackay IR, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev. 2000;174:210\u201325.","journal-title":"Immunol Rev"},{"key":"8838_CR3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. New Engl J Med. 2005;353:1261\u201373.","journal-title":"New Engl J Med"},{"key":"8838_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ng.627","volume":"42","author":"X Liu","year":"2010","unstructured":"Liu X, Invernizzi P, Lu Y, et al. Genome-wide meta-analysis identify three loci associated with primary biliary cirrhosis. Nat Genet. 2010;42:658\u201360.","journal-title":"Nat Genet"},{"key":"8838_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12016-008-8087-9","volume":"36","author":"DP Bogdanos","year":"2009","unstructured":"Bogdanos DP, Vergani D. Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol. 2009;36:30\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"key":"8838_CR6","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/hep.22540","volume":"48","author":"HR Walden","year":"2008","unstructured":"Walden HR, Kirby JA, Yeaman SJ, Gray J, Jones DE, Palmer JM. Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway. Hepatology. 2008;48:1874\u201384.","journal-title":"Hepatology"},{"key":"8838_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2013.08.006","volume":"46","author":"P Invernizzi","year":"2013","unstructured":"Invernizzi P. Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ. J Autoimmun. 2013;46:1\u20136.","journal-title":"J Autoimmun"},{"key":"8838_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1055\/s-2005-916325","volume":"25","author":"H Ishibashi","year":"2006","unstructured":"Ishibashi H, Shimoda S, Gershwin ME. The immune response to mitochondrial autoantigens. Semin Liver Dis. 2006;25:337\u201346.","journal-title":"Semin Liver Dis"},{"key":"8838_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","volume":"1","author":"JG Walker","year":"1965","unstructured":"Walker JG, Doniach D, Roitt IM, Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis. Lancet. 1965;1:827\u201331.","journal-title":"Lancet"},{"key":"8838_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-2007-979469","volume":"27","author":"P Invernizzi","year":"2007","unstructured":"Invernizzi P, Lleo A, Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis. 2007;27:161\u201372.","journal-title":"Semin Liver Dis"},{"key":"8838_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the Liever","year":"2009","unstructured":"European Association for the Study of the Liever. EASL clinical pratice giudelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237\u201367.","journal-title":"J Hepatol"},{"key":"8838_CR12","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386:1565\u201375.","journal-title":"Lancet"},{"key":"8838_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/hep.1840060609","volume":"6","author":"HC Mitchison","year":"1986","unstructured":"Mitchison HC, Bassendine MF, Hendrick A, et al. Positive antimitochondrial antibody but normal alkaline phosphase: is this primary biliary cirrosi? Hepatology. 1986;6:1279\u201384.","journal-title":"Hepatology"},{"key":"8838_CR14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/hep.510250507","volume":"25","author":"P Invernizzi","year":"1997","unstructured":"Invernizzi P, Crosignani A, Battezzati PM, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology. 1997;25:1090\u20135.","journal-title":"Hepatology"},{"key":"8838_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.dld.2004.09.019","volume":"37","author":"L Muratori","year":"2005","unstructured":"Muratori L, Muratori P, Granito A, et al. The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis. Dig Liver Dis. 2005;37:108\u201312.","journal-title":"Dig Liver Dis"},{"key":"8838_CR16","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","volume":"21","author":"S Nezu","year":"2006","unstructured":"Nezu S, Tanaka A, Yasui H, et al. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2006;21:1448\u201354.","journal-title":"J Gastroenterol Hepatol"},{"key":"8838_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/hep.22380","volume":"48","author":"C O\u2019Brien","year":"2008","unstructured":"O\u2019Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcote EJ. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology. 2008;48:550\u20136.","journal-title":"Hepatology"},{"key":"8838_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. American association for study of liver diseases: primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"8838_CR19","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3892\/etm.2015.2694","volume":"10","author":"M Tomizawa","year":"2015","unstructured":"Tomizawa M, Shinozaki F, Fugo K, et al. Anti-mitochondrial m2 antibody-positive autoimmune hepatitis. Exp Ther Med. 2015;10:1419\u201322.","journal-title":"Exp Ther Med"},{"key":"8838_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0168-8278(00)00040-4","volume":"34","author":"P Invernizzi","year":"2001","unstructured":"Invernizzi P, Podda M, Battezzati PM, et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol. 2001;34:366\u201372.","journal-title":"J Hepatol"},{"key":"8838_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","volume":"98","author":"P Muratori","year":"2003","unstructured":"Muratori P, Muratori L, Ferrari R, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol. 2003;98:431\u20137.","journal-title":"Am J Gastroenterol"},{"key":"8838_CR22","first-page":"55","volume":"13","author":"GM Hirschfield","year":"2011","unstructured":"Hirschfield GM, Gerhwin ME. Primary biliary Cirrhosis: one Disease with many faces. IMAJ. 2011;13:55\u20139.","journal-title":"IMAJ"},{"key":"8838_CR23","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","volume":"320","author":"J van de Water","year":"1989","unstructured":"van de Water J, Cooper A, Surh CD et al. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med. 1989;320:1377\u201380.","journal-title":"N Engl J Med"},{"key":"8838_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","volume":"35","author":"H Liu","year":"2010","unstructured":"Liu H, Norman GL, Shums Z, et al. PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;35:436\u201342.","journal-title":"J Autoimmun"},{"key":"8838_CR25","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1373\/clinchem.2008.118299","volume":"55","author":"C D\u00e4hnrich","year":"2009","unstructured":"D\u00e4hnrich C, Pares A, Caballeria I, et al. New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem. 2009;55:978\u201385.","journal-title":"Clin Chem"},{"key":"8838_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","volume":"42","author":"N Bizzaro","year":"2012","unstructured":"Bizzaro N, Covini G, Rosina F, et al. Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: a study of 100 sera and review of the literature. Clin Rev Allergy Immunol. 2012;42:288\u201397.","journal-title":"Clin Rev Allergy Immunol"},{"key":"8838_CR27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/hep.21172","volume":"43","author":"J Wesierska-Gadek","year":"2006","unstructured":"Wesierska-Gadek J, Penner E, Battezzati PM, et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology. 2006;43:1135\u201344.","journal-title":"Hepatology"},{"key":"8838_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for progression of primary biliary cirrhosis. Hepatology. 2007;45:118\u201327.","journal-title":"Hepatology"},{"key":"8838_CR29","first-page":"173","volume":"17","author":"K Kyung-Ah","year":"2011","unstructured":"Kyung-Ah K, Sook-Hyang J. The diagnosis and treatment of primary biliary cirrhosis. J Hepatol. 2011;17:173\u20139.","journal-title":"J Hepatol"},{"key":"8838_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/gast.2002.31880","volume":"122","author":"C Corpechot","year":"2002","unstructured":"Corpechot C, Carrat F, Poupon R, Poupon RE. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology. 2002;122:652\u20138.","journal-title":"Gastroenterology"},{"key":"8838_CR31","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","volume":"101","author":"PC Borg ter","year":"2006","unstructured":"ter Borg PC, Schalm SW, Hansen BE, van Buuren HR. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol. 2006;101:2044\u201350.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"8838_CR32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1665-2681(19)30838-5","volume":"13","author":"WJ Lammers","year":"2014","unstructured":"Lammers WJ, Kowdley KV, van Buuren HR. Predicting outcome in primary biliary cirrhosis. Ann Hepatol. 2014;13(4):316\u201326.","journal-title":"Ann Hepatol"},{"key":"8838_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hep.1840100102","volume":"10","author":"ER Dickson","year":"1989","unstructured":"Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 1989;10:1\u20137.","journal-title":"Hepatology"},{"key":"8838_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hep.1840200120","volume":"20","author":"PA Murtaugh","year":"1994","unstructured":"Murtaugh PA, Dickson ER, van Dam GM, Langworthy A, Gips CH. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology. 1994;20:126\u201334.","journal-title":"Hepatology"},{"key":"8838_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1053\/jlts.2000.6503","volume":"6","author":"WR Kim","year":"2000","unstructured":"Kim WR, Wiesner RH, Poterucha JJ, et al. Adaption of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidate. Liver Transpl. 2000;6:489\u201394.","journal-title":"Liver Transpl"},{"issue":"7","key":"8838_CR36","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;149(7):1804\u201312.","journal-title":"Gastroenterology"},{"key":"8838_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cca.2014.08.024","volume":"438","author":"D Villalta","year":"2015","unstructured":"Villalta D, Sorrentino MC, Girolami E, et al. Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay. Clin Chim Acta. 2015;438:135\u20138.","journal-title":"Clin Chim Acta"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8838-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-016-8838-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8838-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8838-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:49:02Z","timestamp":1749030542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-016-8838-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["8838"],"URL":"https:\/\/doi.org\/10.1007\/s12026-016-8838-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,30]]}}}